United Therapeutics Corporation (UTHR)

United Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,340	1,697	1,208	961.2	894.8	738.7
Short-Term Investments	1,428	1,570	1,786	1,878	1,036	1,096
Cash & Short-Term Investments	2,768	3,267	2,994	2,839	1,931	1,835
Cash Growth	-16.80%	9.12%	5.47%	47.03%	5.21%	23.49%
Accounts Receivable	297.7	279.3	278.9	220.4	198.7	157.4
Other Receivables	-	-	21	70	-	-
Receivables	297.7	279.3	299.9	290.4	198.7	157.4
Inventory	176.5	157.9	111.8	102	93.8	86.5
Other Current Assets	252.2	169.7	145.2	149.2	100.4	88.3
Total Current Assets	3,494	3,874	3,551	3,380	2,324	2,167
Property, Plant & Equipment	1,556	1,222	1,045	861.5	780.9	731.6
Long-Term Investments	1,656	1,534	1,938	1,345	1,681	1,234
Goodwill	-	32.3	33.7	28	28	28
Other Intangible Assets	116.7	79.6	80.5	16.5	16.6	130.1
Long-Term Deferred Tax Assets	354.9	458.4	394.8	327.7	261.9	238.6
Other Long-Term Assets	173.6	163.1	123.3	85.8	77.1	85.1
Total Assets	7,351	7,364	7,167	6,045	5,169	4,615
Accounts Payable	468	6	5.6	4.1	3.8	4.1
Accrued Expenses	-	380.3	358.3	326.1	291.4	298.8
Current Portion of Long-Term Debt	-	300	400	-	-	-
Current Portion of Leases	-	6.1	-	-	-	-
Other Current Liabilities	78.3	45.7	40.5	13	10.2	20.4
Total Current Liabilities	546.3	738.1	804.4	343.2	305.4	323.3
Long-Term Debt	-	-	300	800	800	800
Long-Term Leases	-	32.5	-	-	-	-
Pension & Post-Retirement Benefits	-	21.3	18.3	32	48.9	49.5
Other Long-Term Liabilities	214.6	128.1	59.5	72.6	55.9	47
Total Liabilities	760.9	920	1,182	1,248	1,210	1,220
Common Stock	0.8	0.8	0.7	0.7	0.7	0.7
Additional Paid-In Capital	2,659	2,699	2,549	2,388	2,245	2,149
Retained Earnings	8,193	7,222	6,027	5,042	4,315	3,839
Treasury Stock	-4,262	-3,475	-2,579	-2,579	-2,579	-2,579
Comprehensive Income & Other	0.1	-3.4	-12.8	-55.5	-23	-14.2
Shareholders' Equity	6,590	6,444	5,985	4,797	3,959	3,395
Total Liabilities & Equity	7,351	7,364	7,167	6,045	5,169	4,615
Total Debt	-	338.6	700	800	800	800
Net Cash (Debt)	4,335	4,404	4,204	3,355	2,781	2,185
Net Cash Growth	3.07%	4.75%	25.31%	20.65%	27.28%	55.66%
Net Cash Per Share	89.94	90.80	84.59	69.17	58.79	48.98
Filing Date Shares Outstanding	43.06	44.91	47.06	46.3	45.13	44.54
Total Common Shares Outstanding	42.9	44.83	47.04	46.03	45.11	44.51
Working Capital	2,948	3,136	2,747	3,037	2,018	1,844
Book Value Per Share	153.61	143.74	127.23	104.20	87.77	76.28
Tangible Book Value	6,474	6,332	5,871	4,752	3,914	3,237
Tangible Book Value Per Share	150.89	141.24	124.80	103.24	86.78	72.73
Land	263.6	181.9	148	142.7	132.6	74.9
Buildings	917	863.8	685.3	636.7	612.7	593.6
Machinery	483.6	449.7	381.2	353.9	322.9	325
Construction In Progress	440	218.2	259.1	110.9	55.1	47.4

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q